Rejecting the concept of inevitable dementia, Eugene Bleuler is perhaps ... However, these descriptions apply to all disorders with psychotic features. A patient with psychotic depression may ...

All psychotic symptoms should be viewed as a risk factor for subsequent development of dementia. Management of individuals with dementia requires identification of target behaviours (those most ...

Atypical neuroleptics are appropriate first-line agents for most patients with dementia and psychotic symptoms. Response to medications is modest and a second agent (including acetylcholinesterase ...

People with Parkinson's disease (PD) who experience visual hallucinations have reduced brain responses to unexpected visual changes, a marker known as visual mismatch negativity (vMMN).

Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson's disease and a ...

A study lead by the Economic Evaluation of Chronic Diseases group of Biogipuzkoa Health Research Institute has revealed the relationship between the use of antipsychotics in dementia and ...

Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson's disease and a ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Dear S.S.: Empagliflozin (Jardiance) and dapagliflozin (Farxiga) are both medicines for diabetes in the SGLT2 inhibitor class ...

Why is it that certain medications warn against possible infections in the perineum? I saw an ad for Jardiance that warned ...

Allison was presented with the award by Hilary Woodhead, Executive Director of the National Activity Providers Association ...